Analysts Issue Forecasts for RARE FY2025 Earnings
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) – William Blair issued their FY2025 earnings estimates for shares of Ultragenyx Pharmaceutical in a note issued to investors on Wednesday, May 28th. William Blair analyst S. Corwin anticipates that the biopharmaceutical company will post earnings per share of ($3.48) for the year. William Blair has a “Outperform” […]
More Stories
Adobe Lightroom Review: Features, Pricing & Top Alternatives
Professional photographers have been going gaga over the Adobe Lightroom Classic for years now. Recently, another version of the tool...
Tires Season 3: Release Date, Cast, Plot & Where to Watch
After the surprising hit of Season 2, Tires, brainchild of comedians Shane Gillis, John McKeever, and Steve Gerben, is set...
Top 10 Useless Inventions That Made History for Being Dumb
Iconic inventions of the 18th and 19th centuries, like Edison’s Light Bulb or Charles Babbage’s Computers, have shaped our modern...
Hawk Tuah Girl Hailey Welch Net Worth, Career & Controversy
Hailey Welch, aka the infamous ‘Hawk Tuah’ girl, has become a viral sensation on TikTok and beyond. She has used...
KBC Group NV Has $5.66 Million Stock Position in Emerson Electric Co. (NYSE:EMR)
KBC Group NV grew its position in shares of Emerson Electric Co. (NYSE:EMR – Free Report) by 1.5% during the...
Trump Megabill Clears Rules Vote After Fiscal Conservatives Persuaded
By Joseph Lord and Nathan Worcester WASHINGTON—After House Speaker Mike Johnson (R-La.) and Republican leaders spent hours scrambling to flip...